<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00186407</url>
  </required_header>
  <id_info>
    <org_study_id>BMT92</org_study_id>
    <secondary_id>76379</secondary_id>
    <secondary_id>BMT92</secondary_id>
    <nct_id>NCT00186407</nct_id>
  </id_info>
  <brief_title>Autologous Stem Cell Rescue for Primary Amyloidosis</brief_title>
  <official_title>High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for
      amyloidosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To learn about the use of high dose chemotherapy followed by transplantation using peripheral
      blood stem cells.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 1998</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the role of high dose therapy and autologous hematopoietic cell transplant for amyloidosis</measure>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Amyloidosis</condition>
  <condition>Blood and Marrow Transplant (BMT)</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>high dose chemo then auto hematopoietic cell transplant</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:1. Primary amyloidosis

        2. Age &lt; 75 years.

        3. Patients must have their pathology reviewed and the diagnosis confirmed at Stanford
        University Medical Center.

        4. Patients who have undergone bone marrow transplantation previously will not be eligible.

        5. Patients must have a Karnofsky performance status greater than 70%.

        6. Patients must have a serum creatinine less than 2 mg/dl or creatinine clearance greater
        than 30 ml/min, bilirubin less than 2 mg/dl, transaminases less than two times normal, left
        ventricular ejection fraction &gt;45% on echocardiography, cardiac index &gt; 1.8 liters/min/m^2
        and pulmonary function tests demonstrating FEV1 and DLCO &gt; 60%.

        7. Patients must be HIV negative.

        8. Pregnant or lactating women will not be eligible to participate.

        9. Patients must provide signed informed consent.

        10. Patients with multiple myeloma and amyloid are eligible.

        Exclusion Criteria:1. prior blood or marrow transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sally Arai</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>September 10, 2010</last_update_submitted>
  <last_update_submitted_qc>September 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Sally Arai</name_title>
    <organization>Stanford University School of Medicine</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amyloidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

